Henry Degroot, MD
NPI 1346260411 · Dermatology Physician · Santa Rosa, CA
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Henry Degroot, MD is a Dermatology Physician provider in Santa Rosa, CA (NPI 1346260411).
Provider details
- NPI number
- 1346260411
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- Yes
- License
- A55665 (CA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
6,851 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 2,422 | $8 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 1,417 | $99 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 743 | $59 |
| Biopsy of Related Skin Growth, First Growth11102 | 544 | $105 |
| Destruction of Skin Growth, 1-14 Growths17110 | 302 | $130 |
| Biopsy of Related Skin Growth, Each Additional Growth |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 25 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Triamcinolone Acetonide | 115 | 76 |
| Ketoconazole | 103 | 58 |
| Mupirocin | 99 | 79 |
| Doxycycline Monohydrate | 84 | 50 |
| Metronidazole | 83 | 58 |
| Fluorouracil | 81 | 68 |
| Imiquimod | 54 | 34 |
| Clindamycin Phosphate | 53 | 25 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$2,596 across 115 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-07-20
- Last updated
- 2022-08-01
- Certified
- 2022-08-01
Frequently asked questions
- What is Henry Degroot's NPI number?
- Henry Degroot's National Provider Identifier (NPI) is 1346260411, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Henry Degroot's specialty?
- Henry Degroot is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
- Where is Henry Degroot located?
- Henry Degroot's practice location on file with NPPES is 196 Wikiup Dr, Santa Rosa, CA 95403-7773.
- What is Henry Degroot's phone number?
- The practice phone number listed in the NPPES registry for Henry Degroot is (707) 527-9517.
- Does Henry Degroot accept Medicare?
- Henry Degroot is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Henry Degroot's NPI active?
- Yes — Henry Degroot's NPI (1346260411) is active in the NPPES registry as of the last update on 2022-08-01.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.